{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T17:32:23Z","timestamp":1794159143044,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhep.2025.04.019","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:32:39Z","timestamp":1744479159000},"page":"1011-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-8000","authenticated-orcid":false,"given":"Juan","family":"Vaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-4188","authenticated-orcid":false,"given":"Patrik","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7480-8078","authenticated-orcid":false,"given":"Anders","family":"Helander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-6591","authenticated-orcid":false,"given":"Axel","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8960-3497","authenticated-orcid":false,"given":"Rickard","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2630-9503","authenticated-orcid":false,"given":"Emilie Toresson","family":"Grip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-1759","authenticated-orcid":false,"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.04.019_bib1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10654-023-01028-x","article-title":"Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019","volume":"38","author":"Nasr","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jhep.2025.04.019_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.35097","article-title":"Metabolic dysfunction-associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: a nationwide cohort study","volume":"156","author":"Vaz","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2025.04.019_bib4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2024.01.006","article-title":"Misclassified alcohol-related liver disease is common in presumed metabolic dysfunction-associated steatotic liver disease and highly increases risk for future cirrhosis","volume":"22","author":"Nasr","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2022.04.040","article-title":"Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease","volume":"77","author":"Staufer","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S2468-1253(23)00443-0","article-title":"Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study","volume":"9","author":"Israelsen","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2024.101172","article-title":"ALT levels, alcohol use and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population","author":"M\u00e4nnist\u00f6","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.04.019_bib8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1186\/s12889-019-7987-3","article-title":"Inaccuracies in survey reporting of alcohol consumption","volume":"19","author":"Gilligan","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhep.2025.04.019_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2022.04.026","article-title":"The stigma of alcohol-related liver disease and its impact on healthcare","volume":"77","author":"Schomerus","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1186\/1471-2458-14-1297","article-title":"Drinking pattern is more strongly associated with under-reporting of alcohol consumption than socio-demographic factors: evidence from a mixed-methods study","volume":"14","author":"Boniface","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhep.2025.04.019_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/dta.278","article-title":"Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse","volume":"3","author":"Isaksson","year":"2011","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.jhep.2025.04.019_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/alcalc\/agz064","article-title":"Dose-response characteristics of the alcohol biomarker phosphatidylethanol (PEth)-A study of outpatients in treatment for reduced drinking","volume":"54","author":"Helander","year":"2019","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jhep.2025.04.019_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/alcalc\/agv038","article-title":"Phosphatidylethanol compared with other blood tests as a biomarker of moderate alcohol consumption in healthy volunteers: a prospective randomized study","volume":"50","author":"Kechagias","year":"2015","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jhep.2025.04.019_bib14","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.3390\/ijms131114788","article-title":"Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis","volume":"13","author":"Viel","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.04.019_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/alcalc\/agl027","article-title":"Phosphatidylethanol (PEth) concentrations in blood are correlared to reported alcohol intake in alcohol-dependent patients","volume":"41","author":"Aradottir","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jhep.2025.04.019_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00365513.2023.2253734","article-title":"The alcohol biomarker phosphatidylethanol (PEth) - test performance and experiences from routine analysis and external quality assessment","volume":"83","author":"Helander","year":"2023","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jhep.2025.04.019_bib17","first-page":"101200","article-title":"Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake","author":"Hansen","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.04.019_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jhep.2025.04.019_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jhep.2025.04.019_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhep.2025.04.019_bib21","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cca.2011.04.022","article-title":"Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood","volume":"412","author":"Zheng","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jhep.2025.04.019_bib22","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/dta.3340","article-title":"Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)","volume":"14","author":"Luginb\u00fchl","year":"2022","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.jhep.2025.04.019_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/dta.3432","article-title":"Comment on the upper cutoff level for the alcohol biomarker phosphatidylethanol (PEth) for the assessment of alcohol consumption in forensic practice","volume":"15","author":"Musshoff","year":"2023","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.jhep.2025.04.019_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/alcalc\/agv049","article-title":"Phosphatidylethanol levels are elevated and correlate strongly with AUDIT scores in young adult binge drinkers","volume":"50","author":"Piano","year":"2015","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jhep.2025.04.019_bib25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/1556-4029.13874","article-title":"The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines","volume":"63","author":"Ulwelling","year":"2018","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.jhep.2025.04.019_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/apt.18506","article-title":"Head-to-Head comparison between phosphatidylethanol versus indirect alcohol biomarkers for diagnosis of MetALD versus MASLD: a prospective study","volume":"61","author":"Tavaglione","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.04.019_bib27","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstrom","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.31726","article-title":"Administrative coding in electronic Health care record-based research of NAFLD: an expert panel consensus statement","volume":"74","author":"Hagstrom","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.04.019_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000386","article-title":"The future of International Classification of Diseases coding in steatotic liver disease: an expert panel Delphi consensus statement","volume":"8","author":"Hagstr\u00f6m","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.04.019_bib30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.04.019_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.04.019_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multistate models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.04.019_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.amjmed.2020.08.010","article-title":"The impact of nonalcoholic fatty liver disease in primary care: a population Health perspective","volume":"134","author":"Dokmak","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2025.04.019_bib35","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/dom.15016","article-title":"Nonalcoholic fatty liver disease from a primary care perspective","volume":"25","author":"Clark","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jhep.2025.04.019_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.jhep.2025.04.019_bib37","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"0","author":"Younossi","year":"2024","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib38","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000539371","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"17","year":"2024","journal-title":"Obes Facts"},{"key":"10.1016\/j.jhep.2025.04.019_bib40","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.04.019_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2468-1253(24)00380-7","article-title":"Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective","volume":"10","author":"D\u00edaz","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.04.019_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000603","article-title":"The impact of integrated care on clinical outcomes in patients with alcohol-associated liver disease: early outcomes from a multidisciplinary clinic","volume":"9","author":"Sengupta","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2025.04.019_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.14740\/gr1790","article-title":"Evaluating the impact of phosphatidylethanol testing on hospital outcomes","volume":"17","author":"Haddadin","year":"2024","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.jhep.2025.04.019_bib45","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/acer.15474","article-title":"Impact of phosphatidylethanol in the surveillance for alcohol use in post-liver transplant population: a retrospective study","volume":"48","author":"De La Torre","year":"2024","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"10.1016\/j.jhep.2025.04.019_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049767","article-title":"Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis","volume":"12","author":"Jarvis","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhep.2025.04.019_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/gutjnl-2019-320446","article-title":"Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients","volume":"70","author":"Hagstr\u00f6m","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.04.019_bib48","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825002466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825002466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:49:59Z","timestamp":1763668199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825002466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0168827825002466"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.04.019","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}